Clinical Trial Update: Comparison of MTX+Anti-TNF to MTX+Conventional DMARDs in Patients With Early Rheumatoid Arthritis (RA) Who Failed MTX Alone (SWEFOT) [Phase 4]

View source ↗

Summary

A Phase 4 trial (SWEFOT) evaluated adding an anti-TNF agent to methotrexate versus adding conventional DMARDs to methotrexate in patients with early rheumatoid …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Anti-TNF agents (unspecified)
• Conventional DMARDs (unspecified)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Karolinska Institutet | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED